Hepatitis Archives - Infectious Disease Advisor

HIV, Hepatitis-B Drugs Proven to Reduce Risk of Type 2 Diabetes

By

November 12, 2020

Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.

Hepatitis

Liver Stiffness Post HCV Anti-Viral Therapy Associated With Several Adverse Outcomes

By

Bradley van Paridon

October 21, 2020

Measuring liver stiffness should be considered after anti-viral treatment because it predicts adverse outcomes even beyond routinely available clinical predictors.

Hepatitis

Glecaprevir/Pibrentasvir Effective in Wide Range of Frail HCV Subpopulations

By

Sweta Gupta

October 5, 2020

Italian investigators conducted a prospective, multicenter study to assess the safety and effectiveness of glecaprevir/pibrentasvir in chronic hepatitis C patients and their subpopulations.

Hepatitis

Hepatitis C-Negative Patients Receive Positive Kidney Transplants

By

Zahra Masoud

September 25, 2020

A study published in the Annals of Internal Medicine found transplanting kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative recipients (HCV D+/R-) may be successful with prophylactic treatment with direct-acting antivirals.

Hepatitis

Persistent High Rates of HBsAg Loss With IFN-α in Chronic HBV Suggestive of Its Potential

By

Sweta Gupta

September 23, 2020

Researchers conducted a retrospective medical chart review to analyze relationship between HBsAg loss and a single PEG(IFN-α) course.

Nine Cases of Wound Botulism ID'd in Injection Drug Users

Hepatitis

Cost-Effectiveness of Universal and Targeted Hepatitis C Screening

By

Bradley van Paridon

September 21, 2020

Researchers conducted a simulated economic evaluation cohort analyses to assess the cost-effectiveness of HCV screening and compared other screening programs in the United States.

Hepatitis

Persistent ALT Elevation in HIV-HBV Coinfection May Signal Coexisting Fatty Liver Disease

By

Sweta Gupta

September 16, 2020

Patients with persistent ALT elevation despite controlled HBV should undergo evaluation for metabolic risk and fatty liver disease.

Two studies characterize hematological recovery after CAR-T cell therapy.

Hepatitis

ASCO Issues Provisional Opinion Update on Hepatitis B Screening

By

Leah Lawrence

August 24, 2020

ASCO recommends that patients with newly diagnosed cancer slated to receive systemic anticancer meds be tested for HBV by 3 tests prior to starting therapy.

Hepatitis

Routine Hepatitis C Testing at Federally Qualified Health Centers Would Be Cost-Effective

July 28, 2020

Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections.

The Denver City Council recently passed an ordinance to allow the nation’s first supervised injection site. The Colorado General Assembly must also render an approval. A bipartisan bill to allow the site narrowly failed in a Republican-controlled Senate in 2018, but party control will change in 2019, making its passage more likely.3 Meanwhile, cities including San Francisco and Philadelphia are moving forward with their own site plans, despite warnings from the US Justice Department. Whether in Denver, San Francisco, Philadelphia, or elsewhere, expect the first supervised injection site in the United States to open in the near future, and for a legal battle to follow.

Hepatitis

Efficacy of Bundled HIV, HCV Testing for People With Substance Abuse Disorders Examined

By

Bradley van Paridon

July 22, 2020

By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.